Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5862-5882
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5862
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5862
Table 5 Utilization of healthcare resources during the retrospective 3-year period
| CD | UC | |||||||
| Total | Moderate to severe activity | No or mild activity | P value | Total | Moderate to severe activity | No or mild activity | P value | |
| n | 264 | 118 | 146 | 143 | 36 | 107 | ||
| IBD surgeries | ||||||||
| At least one IBD surgery | 67 (25.4) | 32 (27.1) | 35 (24.0) | 0.559 1 | 4 (2.8) | 1 (2.8) | 3 (2.8) | -- |
| Surgeries, n | 108 | 45 | 63 | 7 | 2 | 5 | ||
| Surgeries/pt, median [range] | 1.0 [1-5] | 1.0 [1-4] | 2 [1-5] | 0.074 | 2.0 [1-2] | 2 | 2.0 [1-2] | -- |
| More than one IBD surgery | 28 (41.8) | 10 (31.2) | 18 (51.5) | 3 (75.0) | 1 (100.0) | 2 (66.7) | ||
| Type [frequency ≥ 5%] | ||||||||
| Partial colectomy | 13 (12.0) | 5 (11.1) | 8 (12.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Total colectomy | 1 (0.9) | 0 (0.0) | 1 (1.6) | 2 (28.6) | 1 (50.0) | 1 (20.0) | ||
| Drainage of anorectal abscess | 6 (5.6) | 3 (6.7) | 3 (4.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Fistulectomy | 22 (20.4) | 9 (20.0) | 13 (20.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Enterostomy | 13 (12.0) | 6 (13.3) | 7 (11.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Enterostomy closure | 5 (4.6) | 5 (11.1) | 0 (0.0) | 2 (28.6) | 0 (0.0) | 2 (40.0) | ||
| IBD hospitaliza-tions | ||||||||
| At least one IBD hospitaliza-tion | 101 (38.3) | 51 (43.2) | 50 (34.2) | 0.136 1 | 28 (19.6) | 11 (30.6) | 17 (15.9) | 0.055 1 |
| Hospitaliza-tions, n | 168 | 93 | 75 | 43 | 18 | 25 | ||
| Hospitaliza-tions/pt, median [range] | 1.0 [1-5] | 2.0 [1-4] | 1.0 [1-5] | 0.031 | 1.0 [1-5] | 1.0 [1-5] | 1.0 [1-3] | 0.978 |
| More than one hospitalization | 47 (46.5) | 29 (56.8) | 18 (36.0) | 10 (35.7) | 4 (36.4) | 6 (35.3) | ||
| Duration (d), median [range] | 6 [1-98] | 5 [0-76] | 4.5 [0-97] | 4 [1-737] | 2.5 [0-20] | 5 [0-737] | ||
| IBD medical appointments | ||||||||
| At least one IBD consultation | 263 (99.6) | 117 (99.2) | 146 (100.0) | 143 (100.0) | 36 (100.0) | 107 (100.0) | ||
| Consultations, n | 3192 | 1466 | 1726 | 1541 | 423 | 1118 | ||
| Consultations /pt, median [range] | 11.0 [1-45] | 12.0 [1-45] | 11.0 [1-35] | 0.801 | 10.0 [1-39] | 9.5 [1-39] | 10.0 [2-30] | 0.896 |
| More than 20 consultations | 27 (10.3) | 15 (12.8) | 12 (8.2) | 9 (6.3) | 4 (11.1) | 5 (4.7) | ||
| Type | ||||||||
| IBD specialist | 2989 (93.6) | 1356 (92.4) | 1633 (94.6) | 1426 (92.5) | 394 (93.1) | 1032 (92.3) | ||
| Emergency | 43 (1.3) | 25 (1.7) | 18 (1.0) | 34 (2.2) | 20 (4.7) | 14 (1.3) | ||
| Other specialist | 160 (5.0) | 85 (5.8) | 75 (4.3) | 81 (5.3) | 9 (2.1) | 72 (6.4) | ||
| Consultations with registered score | ||||||||
| HBI | 11 (0.3) | 1 (0.1) | 10 (0.6) | -- | -- | -- | ||
| CDAI | 103 (3.2) | 54 (3.7) | 49 (2.8) | -- | -- | -- | ||
| Other CD scores | 30 (0.9) | 21 (1.4) | 9 (0.5) | -- | -- | -- | ||
| pMayo score | -- | -- | -- | 95 (6.2) | 12 (2.8) | 83 (7.4) | ||
| Consultations with change of IBD treatment | 522 (16.4) | 269 (18.3) | 253 (14.7) | 0.005 1 | 353 (22.9) | 86 (20.3) | 267 (23.9) | 0.139 1 |
| IBD imaging and laboratory testing | ||||||||
| At least one IBD test | 260 (98.5) | 116 (98.3) | 144 (98.6) | -- | 141 (98.6) | 36 (100.0) | 105 (98.1) | -- |
| IBD tests, n | 5674 | 2722 | 2952 | 2509 | 643 | 1866 | ||
| Tests/pt, median [range] | 19.0 [1-143] | 20.0 [1-143] | 16.0 [1-94] | 0.372 | 15.0 [1-82] | 14.5 [2-82] | 16 [1-75] | 0.767 |
| More than 20 tests | 118 (45.4) | 56 (48.3) | 62 (43.1) | 57 (40.4) | 15 (41.7) | 42 (40.0) | ||
| Type [frequency ≥ 5%] | ||||||||
| Complete blood cell count | 2317 (40.8) | 1077 (39.6) | 1240 (42.0) | 973 (38.8) | 250 (38.9) | 723 (38.7) | ||
| C-reactive protein | 1773 (31.2) | 837 (30.7) | 936 (31.7) | 748 (29.8) | 214 (33.3) | 534 (28.6) | ||
| Serum albumin | 647 (11.4) | 346 (12.7) | 301 (10.2) | 356 (14.2) | 59 (9.2) | 297 (15.9) | ||
| Colonoscopy | 346 (6.1) | 183 (6.7) | 163 (5.5) | 228 (9.1) | 57 (8.9) | 171 (9.2) | ||
- Citation: Parra RS, Chebli JM, Amarante HM, Flores C, Parente JM, Ramos O, Fernandes M, Rocha JJ, Feitosa MR, Feres O, Scotton AS, Nones RB, Lima MM, Zaltman C, Goncalves CD, Guimaraes IM, Santana GO, Sassaki LY, Hossne RS, Bafutto M, Junior RL, Faria MA, Miszputen SJ, Gomes TN, Catapani WR, Faria AA, Souza SC, Caratin RF, Senra JT, Ferrari ML. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World J Gastroenterol 2019; 25(38): 5862-5882
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5862.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5862